Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays.
about
Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancersCan we use methylation markers as diagnostic and prognostic indicators for bladder cancer?The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular CarcinomaMethylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population.Identification of methylated genes associated with aggressive bladder cancer.A global profile of gene promoter methylation in treatment-naïve urothelial cancerIdentification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma.Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancerMultiplexed methylation profiles of tumor suppressor genes in bladder cancer.KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients.Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.Prognostic significance of SOX-1 expression in human hepatocelluar cancer.Bladder cancer: a simple model becomes complex.Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.The role of Sox genes in lung morphogenesis and cancer.The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genesEpigenetic biomarkers in urothelial bladder cancer.Hypomethylating agents for urologic cancers.Global epigenetic profiling in bladder cancer.Hypermethylation in bladder cancer: biological pathways and translational applications.The SOX family of genes in cancer development: biological relevance and opportunities for therapy.Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.DNA methylation-based biomarkers in bladder cancer.Methylation markers for urine-based detection of bladder cancer: the next generation of urinary markers for diagnosis and surveillance of bladder cancer.SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Oncogenic role of SOX9 expression in human malignant glioma.MiniSOX9, a dominant-negative variant in colon cancer cells.Maintaining the unmethylated state.Alteration in methylation pattern of oncogene Akt1 promoter region in bladder cancer.Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors.Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma.SOX9 expression and its methylation status in gastric cancer.A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
P2860
Q21134689-E2AD544C-D7E7-426C-A079-82F9D369BA49Q26744146-C5DEE3E5-8AEC-4BEC-A9F2-B488C94DEDF1Q28071619-8C53A8EF-F266-439E-B88F-124F88B37722Q31058055-81E42C44-A10B-4073-B020-2C770E6AE089Q33680247-C5D4E2D4-DC77-44C6-9D7D-4AA33B8B1F64Q33779194-518F5259-5F3C-44E8-9E79-EAA72FA2F3BBQ33908446-E90A9CA4-68EF-4835-A842-C00DB57B5958Q33976991-FC6A4599-68BC-44EB-9D07-D35FF985EB52Q34202639-00B8DE0C-237C-4600-817B-574DCF02D942Q34760755-33885B80-B3B8-45DA-87FF-819FFDD731FAQ35167858-EA0F2154-CE36-49F1-8F65-31DE8A368A92Q35644340-322D2B9E-AD98-4CCB-9B03-E5AD14334E29Q35854187-93E05304-4917-4811-BAC5-737ECB7DCC7CQ36108115-8C9254A4-7730-4A31-80E2-DE47B5A321C1Q36299435-3DD70E66-65F9-464F-B6A2-803ECA8F27FAQ36538306-5B8A106B-B6A2-4DE3-8939-E662F3193394Q37445834-E4FA3003-E32B-494D-9089-722FA79E53D4Q37451558-68E76C1D-9458-470E-AAED-6C0DA24CEB4EQ37854737-6B810F02-70DA-4452-A040-0B36D1DFDAC0Q37962571-5A8B0F7F-8E9F-4101-8874-1A4128CBB10BQ37978544-43A8EC3A-CBB6-41EC-B03D-75D99DFC4BADQ38029732-79665DFF-9764-486A-9D11-CB0DBB8C9E43Q38068225-E23A3E3D-7405-4BB8-966A-8BC5E3DA0927Q38102879-284C1C53-23E9-4CEC-A532-08C439B85897Q38566949-2D25095F-0611-4E0C-B522-56BE60CB8AEDQ38757541-9DD00EF0-65C2-4639-B19D-1B99E6BE4FCBQ38791381-E7F23510-9FB0-4B62-8210-C8B3AF3AA349Q38833395-A55F8E0C-4613-4B26-BD1A-6665309BECD0Q39328244-7F9B2A32-DF36-4AB1-978A-1AC183D5F1ACQ39597052-EF7BE092-CC38-4A59-B55F-421C78C55F0CQ41847775-944099DF-1B5E-4651-B98A-82BF1256DE1DQ44648798-6A2B1F17-9BA1-4FD8-B03A-DF16F30573BBQ51751167-DF18403F-0083-47A7-996E-9B224D299D4CQ52764125-59AC9317-5813-4682-A5A0-CC3F3AB1973FQ53261686-F9DAD96D-B275-4A9B-B4F8-8B578F8E192FQ54324361-F94483E1-4C9D-4694-94E0-C81574AA46B4Q54357139-89BAC81B-9194-4A9F-A70C-0DD461744C0C
P2860
Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Identification of DNA hypermet ...... ression using CpG microarrays.
@ast
Identification of DNA hypermet ...... ression using CpG microarrays.
@en
type
label
Identification of DNA hypermet ...... ression using CpG microarrays.
@ast
Identification of DNA hypermet ...... ression using CpG microarrays.
@en
prefLabel
Identification of DNA hypermet ...... ression using CpG microarrays.
@ast
Identification of DNA hypermet ...... ression using CpG microarrays.
@en
P2093
P2860
P356
P1476
Identification of DNA hypermet ...... ression using CpG microarrays.
@en
P2093
Cordon-Cardo C
Lopez-Serra L
Sanchez-Carbayo M
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604143
P407
P577
2007-12-18T00:00:00Z